Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 060242/0414 | |
| Pages: | 5 |
| | Recorded: | 06/17/2022 | | |
Attorney Dkt #: | C4019.10002US07 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17787228
|
Filing Dt:
|
06/17/2022
|
Publication #:
|
|
Pub Dt:
|
03/30/2023
| | | | |
Title:
|
DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR
|
|
Assignee
|
|
|
6465 SUNSET DRIVE |
MIAMI, FLORIDA 33143 |
|
Correspondence name and address
|
|
MASCHOFF BRENNAN
|
|
1389 CENTER DRIVE, SUITE 300
|
|
PARK CITY, UT 84098
|
Search Results as of:
06/03/2024 05:59 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|